TABLE 1.

Descriptive Characteristics of the Study Population (N = 312)

Age at enrolment (yrs)
16–29, n (%)	175 (56.1%)
30–39, n (%)	92 (29.5%)
40+, n (%)	45 (14.4%)
Sex
Male, n (%)	127 (40.7%)
Female, n (%)	185 (59.3%)
Highest education level
No education, n (%)	34 (10.9%)
Primary, n (%)	198 (63.5%)
Secondary or more, n (%)	80 (25.6%)
CD4+ cell counts data
Mean initial count (SD)	563 (240)
Median initial count (IQR)	524 (384–717)
Median no. of CD4+ measurements (IQR)	3 (2–4)
Median time interval between consecutive measurements [months(IQR)]	10.3 (3.15–12)
Median interval between seroconversion and initial CD4+ measurements [months(IQR)]	10.3 (8.2–30.7)
Analyses follow up time (mo)
Mean (range)	37.9 (2.0–83.5)
Median (IQR)	35.6 (22.4–51.0)
Initial CD4+ cell count
>500, n (%)	169 (54.2%)
351–500, n (%)	85 (27.2%)
≤350, n (%)	58 (18.6%)
Body mass index
≤20, n (%)	75 (24.0%)
20–24.9, n (%)	196 (62.8%)
25–29.9, n (%)	41 (13.1%)
HIV load (log10)
Mean (SD)	4.69 (0.72)
Median (IQR)	4.76 (4.23–5.27)
HIV-1 subtype
D, n (%)	186 (59.6%)
R, n (%)	59 (18.9%)
A, n (%)	49 (15.7%)
M, n (%)	18 (5.8%)